Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis C in tropical areas].

J M Debonne1, E Nicand, J P Boutin

  • 1Service d'Hépatogastroentérologie, l'Hôpital d'Instruction des Armées Laveran, Marseille, France.

Medecine Tropicale : Revue Du Corps De Sante Colonial
|July 21, 2000
PubMed
Summary

Hepatitis C (HCV) disproportionately affects tropical regions, with two-thirds of infections occurring there. Unsafe injection practices, not just traditional routes, likely drive high prevalence, impacting liver disease significantly.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Progress and challenges for an hepatitis E vaccine].

Virologie (Montrouge, France)·2023
Same author

Bulletin de l'Academie nationale de medecine·2021
Same author

[18<sup>es</sup> Rencontres européennes sur la grippe et sa prévention].

Virologie (Montrouge, France)·2021
Same author

[Lessons from Covid-19].

Bulletin de l'Academie nationale de medecine·2021
Same author

[Covid-19 and the animal world, from a still mysterious origin towards an always unpredictable future].

Bulletin de l'Academie nationale de medecine·2021
Same author

[Covid-19 crisis and National Academy of Medicine].

Bulletin de l'Academie nationale de medecine·2020

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Global Health

Context:

  • Hepatitis C (HCV) epidemiology in tropical regions is poorly understood.
  • An estimated two-thirds of the global HCV-infected population resides in the tropics.
  • High prevalence rates (5-10% or higher) are observed in parts of Africa, China, and Southeast Asia.

Purpose:

  • To elucidate the tropical features of Hepatitis C (HCV).
  • To analyze the prevalence and risk factors of HCV in tropical areas.
  • To investigate the association between HCV and chronic liver diseases in these regions.

Summary:

  • HCV prevalence is high in tropical regions, particularly Africa, China, and Southeast Asia, with rates often exceeding 5%.
  • Age is a significant risk factor, and unsafe parenteral injections are suspected transmission routes beyond blood transfusions and IV drug use.

Related Experiment Videos

  • Genotypes 1, 2, and 3 are most common, with regional variations like genotype 4 in Africa and genotype 6 in Southeast Asia.
  • HCV is linked to 33-50% of non-Hepatitis B chronic liver diseases, showing significant seroprevalence in chronic hepatitis, cirrhosis, and hepatocellular cancer cases.

    • Impact:

    • Highlights the substantial burden of Hepatitis C (HCV) in tropical regions.
    • Suggests a need for targeted public health interventions and improved injection safety practices.
    • Underscores the critical role of HCV in the pathogenesis of chronic liver disease globally.